Search results
Results from the WOW.Com Content Network
Vasculitis [3] Alpidem (Ananxyl) 1995. Worldwide. Not approved in the US, withdrawn in France in 1994 [4] and the rest of the market in 1995 because of rare but serious hepatotoxicity. [3][5] Alosetron (Lotronex) 2000. US. Serious gastrointestinal adverse events; ischemic colitis; severe constipation. [2]
Drug withdrawal. Drug withdrawal, drug withdrawal syndrome, or substance withdrawal syndrome[1] is the group of symptoms that occur upon the abrupt discontinuation or decrease in the intake of pharmaceutical or recreational drugs. In order for the symptoms of withdrawal to occur, one must have first developed a form of drug dependence.
Benzodiazepine dependence (BZD dependence) defines a situation in which one has developed one or more of either tolerance, withdrawal symptoms, drug seeking behaviors, such as continued use despite harmful effects, and maladaptive pattern of substance use, according to the DSM-IV. In the case of benzodiazepine dependence, the continued use ...
Story at a glance Prescriptions of antipsychotic drugs increased for people with dementia substantially in the initial months of the pandemic and remained elevated in 2021, according to a study ...
When compared with people who took DPP-4 inhibitors, those who took SGLT-2 inhibitors had a 35 percent lower chance of developing dementia. Not only that, they had a 52 percent lower risk of ...
145 912.34 g·mol −1. Aducanumab, sold under the brand name Aduhelm, is a monoclonal antibody designed to treat Alzheimer's disease. [2][3] It is a monoclonal antibody [3][2] that targets aggregated forms (plaque) [4][5] of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup. [6][7] It was developed ...
Repeated use of a certain class of drugs for heartburn was linked with a higher risk for dementia among patients in Germany, researchers say. Gastric reflux drugs may be tied to dementia risk Skip ...
Medication discontinuation. Medication discontinuation is the ceasing of a medication treatment for a patient by either the clinician or the patient themself. [1][2] When initiated by the clinician, it is known as deprescribing. [3] Medication discontinuation is an important medical practice that may be motivated by a number of reasons: [4][3]